Do matrix metalloproteinases represent reliable circulating biomarkers in colorectal cancer?
Authors:
Open Access
- 16 August 2016
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 115 (6) , 633-634
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Biomarkers in Colorectal Cancer.2016
- High Expression of Matrix Metalloproteinases: MMP-2 and MMP-9 Predicts Poor Survival Outcome in Colorectal CarcinomaFuture Oncology, 2016
- Colorectal cancer tumour markers and biomarkers: Recent therapeutic advancesWorld Journal of Gastroenterology, 2016
- Plasma matrix metalloproteinase 9 as an early surrogate biomarker of advanced colorectal neoplasiaGastroenterología y Hepatología, 2015
- Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screeningScientific Reports, 2015
- Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targetsTumor Biology, 2013
- Matrix metalloproteinase 2 overexpression and prognosis in colorectal cancer: a meta-analysisMolecular Biology Reports, 2012
- Differences between Human Plasma and Serum Metabolite ProfilesPLOS ONE, 2011
- Serum or Plasma Samples?Arteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasmaClinical Biochemistry, 2007